The Fentanyl Dip Card Test (1 Panel) is a rapid, qualitative immunoassay designed for the detection of fentanyl and its metabolites in human urine at a 10 ng/mL cutoff level. With the growing prevalence of fentanyl-related overdoses in the United States, this test provides a critical tool for early detection and risk mitigation in both clinical and community settings.

Designed in a simple dip-card format, the test delivers fast, reliable preliminary results within minutes, without the need for specialized equipment.

• Single-Panel Fentanyl (FEN) Detection at 10 ng/mL cutoff
• Rapid Results: Clear visual interpretation in 3–5 minutes
• Dip Card Format: Easy-to-use, minimal training required
• High Sensitivity: Detects low levels of fentanyl exposure
• Compact & Portable: Ideal for on-site or field use
• Room Temperature Storage (36–86°F / 2–30°C)

Analyte Detected

• Fentanyl (FEN 10 ng/mL) – Screens for fentanyl and structurally related analogs (cross-reactivity may vary)

Designed to support emerging US drug screening needs, particularly in response to synthetic opioid risks.

How It Works

The test utilizes a competitive immunoassay principle:

• Negative Result: Two lines appear (control + test line)
• Preliminary Positive Result: Only the control line appears
• Invalid Result: No control line appears
  

Packaging & Specifications

• Format: Dip card (urine test strip device)
• Panel: 1 (Fentanyl – FEN)
• Cutoff Level: 10 ng/mL
• Result Time: 3–5 minutes
• Storage Conditions: 36–86°F (2–30°C)
• Shelf Life: Typically 18–24 months (lot-specific)